Subject: Intra-Vitreal Injections/Implants
Within your trust how many intra-vitreal injections/implants have been used in the latest 4 months, if possible between September to December 2017.
If your trust is able to identify injections/implants by eye conditions please split by the drug used [ranibizumab, bevacizumab, aflibercept, Fluocinolone and Dexamethasone].
|We are unable to provide figures by disease state only total numbers for each drug.
The table below shows total numbers used between September and December 2017.
|Lucentis (ranibizumab) Injections||Avastin (bevacizumab) Injections||Eylea (aflibercept) Injections||Illuvien (Fluocinolone) Impants||Ozudex (Dexamethasone) Implants|